T. Calandra

Discipline

Psychologie (5) Economies et finances (5) Sociologie (4) Histoire, Philosophie et Sociologie des sciences (4) Science politique (2)

Type de document

Articles (82) Recensions (17)

Type de document

Mémoires, Thèses et HDR (1)

Co-auteur

Date

Date

Source

Source

Mot-clé

Patients (55) Patients (55) Human beings (48) Treatment (41) Infection (37) infection (34) thérapie (33) Therapeutics (33) Infections (28) mortalité (25) Mortality (25) Mortality (25) Blood (24) adulte (21) adulte (21) Management (20) Use (19) gestion (17) Methods (17) Older people (17) Methods (17) Management (17) Septicemia (16) Days (16) Expression (15) Candidiasis (15) Diagnosis (14) Control (14) Diagnosis (14) Cells (14)

Mot-clé

Development (1) Employment (1) Variation (1) Treatment (1) Clinical pharmacology (1) Sports records (1) Signs and symbols (1) Progress (1) Prediction theory (1) Mycoses (1) Miracles (1) Medical microbiology (1) Liquids (1) Licenses (1) International organization (1) Impact (1) High pressure (Technology) (1) High pressure (Science) (1) Evidence (1) Division (1) Communicable diseases (1) Clinics (1) Candida (1) Breast (1) Blood plasma (1) Athletic ability (1) Use studies (1) Use studies (1) Technique (1) Toxicology (1)

Documents écrit par T. Calandra (82) | parle de T. Calandra (1)

COVID-19 rapidly increases MDSCs and prolongs innate immune dysfunctions.
I.T. Schrijver et al.
Κey Role of Early Source Control in Candidemic Patients With Sepsis or Septic Shock.
M. Papadimitriou-Olivgeris et al.
Bas les masques, et après ?
L. Kaiser et al. (13 avr. 2022)
High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus.
J. Herderschee et al.
High levels of monocytic myeloid-derived suppressor cells are associated with favorable outcome in patients with pneumonia and sepsis with multi-organ failure.
I.T. Schrijver et al. (11 févr. 2022)
Increasing morbidity and mortality of candidemia over one decade in a Swiss university hospital.
J. Battistolo et al.
Initial antimicrobial management of sepsis.
M.S. Niederman et al. (26 août 2021)
The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients.
M. Perreau et al. (9 août 2021)
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis.
P.E. Verweij et al.
SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.
S. Meylan et al. (5 juil. 2021)
Invasive Pulmonary Aspergillosis Goes Viral Again?
J. Wauters et al. (1 févr. 2021)
An Early Warning Score to predict ICU admission in COVID-19 positive patients.
S. Meylan et al.
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.
P.E. Verweij et al.
Coronavirus et fragilité []
L. Kaiser et al. (15 avr. 2020)
Performance of the T2Candida Panel for the Diagnosis of Intra-abdominal Candidiasis.
F. Lamoth et al.
Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector.
M. Giel-Moloney et al. (27 déc. 2019)
IRF5 Is a Key Regulator of Macrophage Response to Lipopolysaccharide in Newborns.
A. Schneider et al. (2018)
Prognostic value of quickSOFA as a predictor of 28-day mortality among febrile adult patients presenting to emergency departments in Dar es Salaam, Tanzania.
N. Boillat-Blanco et al. (2018)
Low sensitivity of qSOFA, SIRS criteria and sepsis definition to identify infected patients at risk of complication in the prehospital setting and at the emergency department triage.
S. Tusgul et al. (3 nov. 2017)
ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients.
F. Tissot et al.
Role of TLR1, TLR2 and TLR6 in the modulation of intestinal inflammation and Candida albicans elimination.
L. Choteau et al. (2017)
Plasma Levels of Macrophage Migration Inhibitory Factor and d-Dopachrome Tautomerase Show a Highly Specific Profile in Early Life.
T. Roger et al. (2017)
Le facteur d’inhibition de la migration des macrophages (MIF), un régulateur de la réponse immunitaire innée néonatale [Macrophage migration inhibitory factor (MIF), a regulator of neonatal innate immune response]
É. Giannoni et al.
Novel strategies for targeting innate immune responses to influenza.
K.A. Shirey et al.
Diagnosis and management of invasive candidiasis in the ICU: an updated approach to an old enemy.
T. Calandra et al. (27 mai 2016)

next
Variability of voriconazole plasma levels measured by new high-performance liquid chromatography and bioassay methods, [and] Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes
A. Pascual (2010)